Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-01-27 @ 1:03 AM
Study NCT ID:
NCT03041259
Status:
UNKNOWN
Last Update Posted:
2018-08-09
First Post:
2017-01-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction
Sponsor:
Reven Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-07
Completion Date Type:
ESTIMATED
First Submit Date:
2017-01-27
First Submit QC Date:
None
Study First Post Date:
2017-02-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-07
Last Update Post Date:
2018-08-09
Last Update Post Date Type:
ACTUAL